Skip to main content
. 2018 Apr 13;9(28):19793–19806. doi: 10.18632/oncotarget.24857

Figure 2. Distribution of case samples before and after chemotherapy, contrasted by samples from healthy control subjects.

Figure 2

NSCLC (A) and SCLC (B).